相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial
Evan L. Fogel et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography
Takeshi Tomoda et al.
GASTROENTEROLOGY (2019)
A randomized trial comparing the efficacy of single-dose and double-dose administration of rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis
Jian-Han Lai et al.
MEDICINE (2019)
End of the Road for Epinephrine Spraying of the Papilla to Prevent Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis?
Mark A. Gromski et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography
Hui Luo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients
Ayesha Kamal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials
Yunxiao Lyu et al.
BMC GASTROENTEROLOGY (2018)
Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials
Arpad Patai et al.
GASTROINTESTINAL ENDOSCOPY (2017)
Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis
Sumant Inamdar et al.
GASTROINTESTINAL ENDOSCOPY (2017)
Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial
Shaffer R. S. Mok et al.
GASTROINTESTINAL ENDOSCOPY (2017)
Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients
John M. Levenick et al.
GASTROENTEROLOGY (2016)
Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography
Nikhil R. Thiruvengadam et al.
GASTROENTEROLOGY (2016)
Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial
Hui Luo et al.
LANCET (2016)
Rectal indomethacin alone versus indomethacin and prophylactic pancreatic stent placement for preventing pancreatitis after ERCP: study protocol for a randomized controlled trial
B. Joseph Elmunzer et al.
TRIALS (2016)
Use of Celecoxib Correlates With Increased Relative Risk of Acute Pancreatitis: A Case-Control Study in Taiwan
Shih-Chang Hung et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials
Bharati Kochar et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis A Systematic Review and Meta-analysis
Tarun Rustagi et al.
PANCREAS (2015)
lOral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study
Tae Yoon Lee et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2015)
A Randomized Trial of Rectal Indomethacin and Sublingual Nitrates to Prevent Post-ERCP Pancreatitis
Rasoul Sotoudehmanesh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis
Takero Mazaki et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Systematic review with network meta-analysis: pharmacological prophylaxis against post-ERCP pancreatitis
V. S. Akshintala et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Rectal Nonsteroidal Anti-inflammatory Drugs Are Superior to Pancreatic Duct Stents in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Network Meta-analysis
Ali Akbar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial
P. Katsinelos et al.
ENDOSCOPY (2012)
Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial
Taiga Otsuka et al.
JOURNAL OF GASTROENTEROLOGY (2012)
A Randomized Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
B. Joseph Elmunzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review
Abhishek Choudhary et al.
GASTROINTESTINAL ENDOSCOPY (2011)
Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis
Manouchehr Khoshbaten et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high-risk patients: a randomized double-blind prospective trial
Young Koog Cheon et al.
GASTROINTESTINAL ENDOSCOPY (2007)
Incidence rates of post-ERCP complications: A systematic survey of prospective studies
Angelo Andriulli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP
Rasoul Sotoudehmanesh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Acute pancreatitis - Animal models and recent advances in basic research
Yuk Cheung Chan et al.
PANCREAS (2007)
Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis
H. T. Sorensen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
REDUCING THE INCIDENCE AND SEVERITY OF POST ERCP PANCREATITIS
W. R. Murray
SCANDINAVIAN JOURNAL OF SURGERY (2005)
Prevention of post-ERCP pancreatitis: a comprehensive review
ML Freeman et al.
GASTROINTESTINAL ENDOSCOPY (2004)
COX-2 inhibition results in alterations in nuclear factor (NF)-κB activation but not cytokine production in acute pancreatitis
MI Slogoff et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2004)
Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholanglopancreatography
B Murray et al.
GASTROENTEROLOGY (2003)
Inhibition of cyclooxygenase-2 ameliorates the severity of pancreatitis and associated lung injury
AM Song et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Cyclooxygenase-2 gene disruption attenuates the severity of acute pancreatitis and pancreatitis-associated lung injury
RT Ethridge et al.
GASTROENTEROLOGY (2002)
Differential regulation of cyclooxygenase-2 (COX-2) mRNA stability by interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in human in vitro differentiated macrophages
ZF Huang et al.
BIOCHEMICAL PHARMACOLOGY (2000)